tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of James Edwardes Jones, 21 are a SELL (23.86%), 47 are a BUY (53.41%), 20 are a HOLD (22.73%).
Analyst James Edwardes Jones, currently employed at RBC, carries an average stock price target met ratio of 39.3% that have a potential upside of 27.58% achieved within 219 days.
James Edwardes Jones’s has documented 159 price targets and ratings displayed on 20 stocks. The coverage is on Consumer Defensive, Healthcare, Technology, Industrials sectors.
Most recent stock forecast was given on UL, Unilever PLC ADR at 21-Apr-2026.
Analyst best performing recommendations are on CYCC (CYCLACEL PHARMACEUTICALS).
The best stock recommendation documented was for CYCC (CYCLACEL PHARMACEUTICALS) at 3/7/2023. The price target of $10 was fulfilled within 3 days with a profit of $0.93 (8.51%) receiving and performance score of 28.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Jun-2026
$34.5
4 months 2 days ago
(08-Jun-2026)
4/4 (100%)
$0.7 (2.07%)
162
Sell Since 28-Feb-2026
$42.31
7 months 12 days ago
(28-Feb-2026)
2/2 (100%)
$12.05 (39.82%)
1127
Hold Since 08-Sep-2025
$50
1 years 1 months 2 days ago
(08-Sep-2025)
1/1 (100%)
$22.38 (81.03%)
1490
Hold Since 31-May-2023
1 years 10 months 13 days ago
(27-Nov-2024)
7/7 (100%)
$10.64 (40.86%)
960
Buy Since 17-Sep-2018
$41.84
$-13.66 (-24.61%)
$37.8
2 years 8 months 18 days ago
(22-Jan-2024)
3/3 (100%)
$17.03 (68.64%)
1649
Which stock is James Edwardes Jones most bullish on?
What Year was the first public recommendation made by James Edwardes Jones?
